Sinocare Inc.
Steve Riendeau serves as Chief Commercial Officer at Sinocare Inc., overseeing PTS Diagnostics and Trividia Health since February 2022. Previously, Riendeau held the role of VP Global Sales at PTS Diagnostics, where responsibilities included designing and leading the international commercial strategy for the CardioChek system and rebuilding the commercial organization following an FDA warning. Prior to that, Riendeau was Executive Director of Eastern U.S. operations at Specialty Laboratories/Ameripath, focusing on turnaround strategies after a CMS citation. Early career experience includes a Sales Manager position at Myriad Genetics, where Riendeau contributed to the commercialization strategy for BRCA1 and BRCA2 genetic testing. Educational background includes a Bachelor of Science in Economics from Florida State University.
This person is not in any teams
This person is not in any offices
Sinocare Inc.
As a high-tech company, Sinocare Inc. has been dedicating itself to bio-sensor technology research & development, manufacturing and marketing of POCT products since its establishment in Aug,2002. Sinocare focuses intensively and extensively on the R&D of products and innovation of technology, casting our look into the future, to deliver significant benefits for people pursuing healthy living. In March, 2012, Sinocare Inc. was listed on Shenzhen Stock Exchange, abbreviated as "Sinocare" with stock code 300298. We passed ISO13485 and our products were certified by EU CE. The company's Sinocare glucometer series and its test strips has won an universal recognition from a large number of consumers thanks to its accuracy, simplicity and affordability. The product is not only popular in China, but also exports in large scale. Observing the values of “equality, honesty, innovation and excellence”, Sinocare conducts continuous innovation and establishes "portable laboratory" based on POCT product. The company aims at providing quality product and service for China’s chronic disease management, help chronic disease patients improve living quality and reduce the burden of social medical care system.